Kenvue
Prezzo: 18.14Società e modello di business
Kenvue (KVUE.US) operates in the consumer staples sector, focusing on personal care and hygiene products. Its core offerings include over-the-counter medications, skincare, and household cleaning products. Major business segments encompass health and wellness, beauty, and home care, with primary revenue sources derived from product sales in retail and e-commerce channels.
Profilo di investimento
The investment profile of Kenvue is more aligned with dividend investors due to its notable dividend yield of 6.0%. The stock exhibits moderate growth potential, making it suitable for those seeking a balance between income and capital appreciation. Its relatively stable performance and low volatility suggest a lower risk profile, appealing to investors with a medium to long-term horizon.
Metriche fondamentali (sperimentale)
- EPS (TTM) — utile per azione degli ultimi 12 mesi, $
- 0.85 OK
- Ricavi QoQ — crescita dei ricavi trimestre su trimestre
- 3.4% ↑
- Sorpresa EPS
- 18.5% meglio del previsto
- Volatilità 20g
- 1.6% stabile
- Rendimento dividendo
- 4.6% alto ultima data ex-dividendo: 2026-05-13
Traccia in portafoglio
Grafico prezzo
| Data | Prima | Dopo | Motivo |
|---|---|---|---|
| 2026-06-10 00:48 | Mantieni | Compra | Strong fundamentals and solid dividend yield support growth. |
| 2026-05-30 02:43 | Compra | Mantieni | Stable dividend, but weak momentum and high risk. |
| 2026-05-22 02:50 | Mantieni | Compra | Stable dividend, moderate growth, mixed momentum signals. |
| Data | Analista | Action | Target | Prezzo allora |
|---|---|---|---|---|
| 2026-04-14 12:53 | Barclays | Target abbassato | 19 → 18 | 17.385 |
| 2026-02-18 12:42 | UBS | Target alzato | 17 → 19 | 18.41 |
| 2026-02-18 12:10 | Canaccord Genuity | Target alzato | 17 → 18 | 18.41 |
Ancora nulla